Skip to main content

Table 2 Analysis of numerous factors that might be related to overall survival

From: Oncological and functional results of the surgical treatment of vertebral metastases in patients with multiple myeloma”

  Number of patients p-value
Age
  < 65 years 43 (33%) <0.05
  > 65 years 86 (67%) <0.05
Stage of disease (Salmon-Durie)
 I 8 (6%) Ns
 II 20 (16%) Ns
 III 101(78%) <0.05
Radiotherapy
 Yes 85 (66%) Ns
 No 44 (34%) Ns
Time to initial diagnosis
  < 1 year 23 (8%) Ns
 1–2 years 48 (37%) Ns
  > 3 years 71 (55%) <0.05
CRP level
  < 5 mg/l 91 (70%) Ns
  > 5 mg/l 38 (30%) Ns
Peripheral blood stem cell transplantation
 Yes 71 (55%) Ns
 No 58 (45%) Ns
Lactate dehydrogenase
  < 240 U/l 93 (72%) Ns
  > 240 U/l 36 (28%) Ns
Beta-2 microglobulin
  < 3.5 mg/l 8 (6%) Ns
 3.5–5.5 mg/l 31 (24%) Ns
  > 5.5 mg/l 90 (70%) Ns